Globally, cervical cancer is the fourth most common cancer in women, with 6,04,000 new cases in 2020. Women living with HIV are 6 times more likely to develop cervical cancer, compared to the general population, and an estimated 5% of all cervical cancer cases are attributable to HIV. The contributi

2 views • 7 slides

The Canadian Cancer Research Alliance (CCRA) is a collaboration of organizations funding cancer research in Canada to advance prevention, diagnosis, and treatment. Established in 2005, CCRA has grown to over 35 members and published strategic plans to enhance cancer research outcomes. The Alliance s

2 views • 40 slides

Pioneering cancer nurses in Europe are driving advancements in cancer care through innovative approaches, evidence-based knowledge, and personalized patient-centered care. They play a vital role in cancer prevention, healthcare policy enhancement, and education improvement. By putting patients and f

0 views • 12 slides

The Europe Cancer Diagnostics Market is projected to reach $12.21 billion by 2031, at a CAGR of 5.6% during the forecast period 2024\u20132031. The Europe cancer diagnostics market is driven by the rising prevalence of cancer, supporting initiatives for early cancer diagnosis, increasing investments

3 views • 4 slides

The Canadian Cancer Statistics 2023 report provides a comprehensive analysis of cancer data, including trends, statistics, and insights for the year. The report covers various aspects of cancer, such as incidence rates, survival rates, types of cancers diagnosed, and advancements in cancer treatment

0 views • 31 slides

The prostate is a soft organ in reproductive anatomy. It is nearly about the size of a chestnut. Its weight is around 30 grams. It is located in the pelvis below the bladder with the urethra passing through. It is surrounded by an elastic, fibromuscular capsule and contains glandular tissue and conn

1 views • 2 slides

Abiraterone acetate is a medication primarily prescribed to treat prostate cancer. It works by blocking the production of testosterone, a hormone that fuels the growth of prostate cancer cells. This medication is usually used in combination with other treatments. It's important to follow your doctor

4 views • 3 slides

The Cancer Therapy Evaluation Program (CTEP) aims to enhance cancer patients' lives by advancing cancer treatment through research and clinical trials. The Program includes a Protocol and Information Office (PIO) to streamline trial development processes. It funds national cancer research and focuse

0 views • 27 slides

This comprehensive guide explores the definitions, uses, and levels of screening and prevention in family medicine. It covers the criteria for screening tests, types of screening, examples of targeted populations, and approaches to preventing common problems in primary care. The content discusses th

0 views • 73 slides

The presentation by Caterina Gentili, PhD candidate, on body image issues and exercise attitudes in men diagnosed with prostate cancer undergoing androgen deprivation therapy sheds light on the challenges faced by this population. The background discusses the increasing number of prostate cancer sur

0 views • 45 slides

Cancer Alliances play a crucial role in coordinating cancer care and improving outcomes for patients. The South West Lung Pathway Transformation focuses on implementing rapid assessment pathways for lung, prostate, and colorectal cancers. Their priorities include meeting waiting time standards, diag

0 views • 23 slides

Cancer nurses play a crucial role in raising awareness about effective cancer prevention methods, supporting the European Code Against Cancer, providing advice for risk reduction, promoting health literacy, and encouraging early diagnosis through screening programs. Their expertise and leadership ar

0 views • 30 slides

The Canadian Partnership Against Cancer annually collects and summarizes data on national, provincial, and territorial prostate cancer screening guidelines and strategies. Despite the absence of organized screening programs, some provinces have policies in place, with opportunistic screening by prim

0 views • 13 slides

The Cancer Genome Atlas (TCGA) project, initiated in 2005, aims to identify genetic mutations in cancer through genome sequencing. Supervised by the Center for Cancer Genomics, TCGA has expanded over the years, publishing numerous research articles and involving various tumor types. The project has

0 views • 7 slides

Ronald Chen, MD MPH discusses reducing radiation treatment time and the effectiveness and safety of different fractionation schedules in prostate cancer treatment. Various hypofractionation regimens are explored, with moderate hypofractionation showing promising results in clinical trials for differ

0 views • 23 slides

Cancer survival rates in Europe have shown variations across different types of cancer and countries. While overall cancer mortality has increased over the years, some countries have experienced declines in mortality rates. Survival rates for breast cancer between 1995-2014 ranged from 74% to 89%, w

0 views • 17 slides

Exploring the concept of cancer health disparities, this content touches on the National Cancer Act of 1971, the impact of social determinants of health, and various initiatives such as the National Minority Cancer Awareness Week. It highlights efforts to reduce disparities through research, advocac

6 views • 8 slides

Cancer is a disease characterized by the uncontrollable growth and spread of abnormal cells in the body. These cells form tumors that can be either cancerous (malignant) or non-cancerous (benign). Cancer can develop in various parts of the body and is often caused by genetic changes that affect cell

2 views • 21 slides

Data submission in cancer registry systems serves the purpose of contributing to a larger pool of information for monitoring cancer trends, determining patterns, guiding program planning, and assisting public health professionals. Organizations like the State Central Cancer Registries and national p

1 views • 11 slides

Recent studies have shown advancements in anticoagulation therapy for cancer patients with venous thromboembolism (VTE) and stroke prevention. Direct oral anticoagulants (DOACs) are now considered beneficial for treating VTE in cancer, offering advantages in administration and efficacy. Different an

3 views • 9 slides

Investigating the disparities in prostate cancer among Black and White men, Dr. Renee Reams conducted research highlighting real differences in prostate tumors based on race. RNA sequencing analysis explored possible genetic predispositions in Black men, raising questions about inflammation factors

0 views • 11 slides

The Humber, Coast and Vale Cancer Alliance's Cancer Champions Programme, led by Trish Rawnsley, aims to raise awareness and promote early diagnosis of cancer. Developed in North East Lincolnshire in 2011, the program has trained almost 1,000 individuals, resulting in lower emergency presentations in

0 views • 10 slides

Cancer registries serve as vital information systems for collecting, storing, and analyzing cancer data to aid in research, prevention, treatment, and public health efforts. They help track cancer incidence, assist in identifying trends, and provide essential information to healthcare professionals

0 views • 18 slides

Activities focusing on standardizing cancer care in Europe include quality assurance of screening programs, defining survivorship, establishing Comprehensive Cancer Control Networks, addressing socio-economic inequalities, and promoting public health genomics. The European Cancer Patient Coalition e

0 views • 7 slides

National Cancer Patient Experience Survey (NCPES) for 2021 focused on brain tumour patients and was led by Lisa Wilks, the Lead Cancer Nurse at NBT. The survey, commissioned by NHS England, aimed to monitor cancer care progress, drive quality improvements, and inform stakeholders. Methodology includ

0 views • 26 slides

Explore the normal anatomy and histology of the testis and prostate in the male reproductive system. Detailed images and descriptions provide insights into the structures and functions of these important organs. Understand the gross and microscopic features of the testis, including seminiferous tubu

0 views • 39 slides

Alcohol consumption is linked to an increased risk of various cancers, including mouth, throat, esophagus, breast, liver, and colorectal cancers. Factors such as ethanol, acetaldehyde, nutrient absorption, estrogen levels, and liver cirrhosis play a role in this risk. Even light drinking can elevate

0 views • 17 slides

The journey of cancer diagnosis brings forth various challenges, including misconceptions about nutrition. Debunking myths like soy stimulating cancer cells, sugar feeding cancer, and acidic diets curing cancer is crucial for informed decision-making. Evidence shows that soy can be a part of a healt

1 views • 11 slides

Lead by Catherine Neck, the Macmillan Cancer Rehabilitation/Recovery Package Project aims to enhance cancer care services. The Cancer Transformation Funding supports initiatives for breast, colorectal, and prostate cancers, including holistic needs assessments and wellbeing events. The SWAG Cancer A

0 views • 7 slides

This scheme by Wessex Cancer Alliance focuses on improving prevention and early diagnosis of cancer at the local level, with funding allocated on a per-patient basis. Requirements include appointing clinical and non-clinical cancer champions, completing reporting tasks, and participating in webinars

0 views • 6 slides

The data presented showcases global cancer statistics from various years, highlighting the prevalence of different types of cancer across genders. It includes information on the estimated number of cancer cases, common types of cancers, and trends expected up to 2035. Lung cancer, breast cancer, and

0 views • 83 slides

Describes the successful integration of Complementary Medicine in the network of Cancer Departments within the Tuscan Public Healthcare System. The initiative, spearheaded by experts in both Complementary Medicine and medical oncology, has led to the development of Regional Guidelines incorporating

0 views • 4 slides

Europa Uomo Summer School 2024 offers an intensive learning experience on prostate cancer, clinical trials, and more. The program includes sessions on molecular principles, cancer development, statistics, clinical trials, PSA measurement, and prostate cancer evolution. Participants will delve into v

0 views • 11 slides

Prostate cancer is a significant health concern among men, characterized by abnormal cell growth in the prostate gland. This cancer can spread locally or metastasize, leading to different stages such as localized, locally advanced, and metastatic prostate cancer. Dr. Hiralal Chaudhari explains the c

0 views • 14 slides

Prostate cancer, a significant health concern worldwide, has seen advancements in treatment with the adoption of IMRT. However, the use of radiotherapy poses risks of inducing secondary cancers due to organ toxicity. A study presented at ICARO3 focused on evaluating the toxicity of organs at risk an

0 views • 6 slides

Cancer survival statistics in England, analyzed in collaboration between Public Health England (PHE) and the Office for National Statistics (ONS), provide crucial insights into the effectiveness of cancer services. These statistics measure the mortality rates of cancer patients and inform various st

0 views • 25 slides

Learn about the spending on various types of cancer in Europe including breast cancer, colorectal cancer, prostate cancer, lung cancer, ovary cancer, and pancreatic cancer. The information is based on the Comparator Report on Cancer in Europe 2019, which covers disease burden, costs, and access to m

2 views • 7 slides

The Prostate Collaborative Group is actively working on various research projects related to the detection and evaluation of prostate cancer biomarkers. Updates on research statuses, innovative imaging and urine testing methods, development of protein biomarkers, and biomarkers for early detection o

0 views • 8 slides

The SWAG Cancer Services National Cancer Patient Experience Survey Results for 2021 provide insights into the experiences of skin cancer patients in Somerset, Wiltshire, Avon, and Gloucestershire. The survey, commissioned by NHS England, aims to monitor progress in cancer care, drive local quality i

0 views • 27 slides

The HERO study compared the efficacy of oral GnRH receptor antagonist, Relugolix, with the commonly used ADT, Leuprolide Acetate, in treating advanced prostate cancer. Results showed that Relugolix achieved sustained castration more effectively than Leuprolide, with superior testosterone suppression

0 views • 29 slides